- Report
- January 2024
- 200 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- February 2024
- 185 Pages
Global
From €4701EUR$4,900USD£4,038GBP
- Report
- May 2024
- 183 Pages
From €3237EUR$3,374USD£2,781GBP
€3596EUR$3,749USD£3,090GBP
- Report
- April 2023
- 120 Pages
Global
From €4557EUR$4,750USD£3,914GBP
- Report
- June 2021
- 50 Pages
China
From €2494EUR$2,600USD£2,143GBP
- Report
- October 2023
- 83 Pages
Global
From €3500EUR$3,908USD£3,112GBP
- Report
- November 2022
- 76 Pages
Global
From €1919EUR$2,000USD£1,648GBP
- Drug Pipelines
- June 2020
- 65 Pages
Global
From €1919EUR$2,000USD£1,648GBP
- Report
- May 2024
- 50 Pages
Global
From €2542EUR$2,650USD£2,184GBP
Rabeprazole is a proton pump inhibitor (PPI) used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease. It is also used to reduce the risk of gastric ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Rabeprazole works by blocking the production of acid in the stomach, which helps to reduce symptoms of acid reflux and other gastrointestinal disorders.
Rabeprazole is available in both generic and brand-name formulations. It is typically taken once daily, and is available in tablet, capsule, and oral suspension forms. Common side effects of rabeprazole include headache, nausea, diarrhea, and abdominal pain.
Rabeprazole is one of the most commonly prescribed PPIs for the treatment of gastrointestinal disorders. It is widely available in pharmacies and is covered by most insurance plans.
Some companies that produce rabeprazole include Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, and Teva Pharmaceuticals. Show Less Read more